Reed's, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a REED research report →
Range $4.75 – $10.5
Price Chart
About the company
Reed's, Inc. (symbol: REED) operates as a manufacturer and distributor of premium, all-natural handcrafted beverages. These artisanal concoctions, part of the craft specialty foods sector, are available across a wide geographical footprint, spanning the United States, Canada, Asia, Europe, Australia, and South America.
- CEO
- Neal Cohane
- IPO
- 2006
- Employees
- 44
- HQ
- Norwalk, CT, US
Get TickerSpark's AI analysis on REED
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $11.94M
- P/E
- -0.55
- PEG
- -0.01
- P/S
- 0.41
- P/B
- -8.06
- EV/EBITDA
- -0.59
- Div Yield
- 0.00%
- Gross Margin
- 17.98%
- Op Margin
- -61.39%
- Net Margin
- -63.48%
- ROE
- -564.24%
- ROIC
- 2698.64%
Latest fiscal year · YoY change
- Revenue
- $34.06M-10.2%
- Gross Profit
- $6.96M-38.8%
- Op Income
- $-15,148,000
- Net Income
- $-15,847,000-20.5%
- EPS
- $-1.91-16.5%
- OCF Growth
- -178.2%
- FCF Growth
- -175.9%
- 52W High
- $12.00
- 52W Low
- $0.73
- 50D MA
- $1.12
- 200D MA
- $2.90
- Beta
- 0.29
- RSI (14)
- 50
- Avg Volume
- 22.33K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Reed's posted sequential improvement in Q2 as gross margin, inventory, and operating losses improved, but sales were still down year over year and the company said more work remains to reach profitable growth.· August 12, 2026
- Net sales were $7.5 million, down from $9.5 million a year ago, but up 5% sequentially from Q1 2026.
- Gross profit rose to $1.8 million and gross margin expanded to 24% from 8%, helped by inventory write-offs falling to $0.1 million from $1.6 million.
- SG&A fell 6% year over year to $4.7 million; net loss improved to $4.3 million, or $(0.36) per share, from $6.0 million, or $(0.78) per share.
- Inventory was reduced to $7 million, cash used in operations improved to $2.2 million, and management said it is evaluating financing alternatives.
- Management emphasized shelf-space recovery, glass-bottle reintroductions, new SKUs, and further margin expansion toward the mid-30% range over time.
Second quarter 2026 net sales were $7.5 million versus $9.5 million in the prior-year period. Gross profit was $1.8 million, up from $0.8 million, and gross margin was 24% versus 8% a year ago. Net loss improved to $4.3 million, or negative $0.36 per share, from $6.0 million, or negative $0.78 per share; EBITDA loss narrowed to $4.0 million from $5.7 million. Cash used in operations was $2.2 million versus $5.0 million, and cash at June 30, 2026 was $2.4 million with $9.2 million of total debt. For guidance, management did not give formal quarterly or full-year financial targets, but said gross margin is expected to continue expanding over time toward the mid-30% area, inventory should come down further in Q3, and the company is evaluating financing alternatives to support growth.
Neal Cohane said the quarter showed early progress from corrective actions, but stressed that the company is still not where it wants to be. His focus was on better sales execution, retail placement, operating efficiency, and a leaner inventory model after substantially completing portfolio rationalization. He also pointed to regained shelf space, the return of heritage glass bottles, new product launches, and a more disciplined commercial and operations setup as the basis for second-half improvement.
Douglas McCurdy highlighted the year-over-year improvement in gross profit, margin, and losses, tying the margin rebound mainly to lower inventory write-offs. He cited delivery and handling costs of $1.1 million, down 30%, and SG&A of $4.7 million, down 6%, while noting that personnel investment for the Asia growth initiative partly offset savings. He also said cash used in operations improved to $2.2 million, cash ended at $2.4 million, debt was $9.2 million, and the company is evaluating financing alternatives.
Analyst questions focused on vendor relationships, shelf-space recovery, inventory readiness, and whether Reed's can support growth given the balance sheet. Neal Cohane said relationships with major accounts remain intact, named several chains the company has already contacted, and said commitments should start showing up toward the end of Q3 and into Q1 next year. He also said new production arrangements should lower minimum order quantities and help preserve cash, while pricing actions and an AI-supported system are intended to push margins into the 30s and mid-30s.
The company is showing sequential operating improvement, with sales up 5% from Q1, gross margin at 24%, and losses and cash burn improving. Management sounded more confident about regained retail relationships, glass-bottle reintroductions, and new SKUs, and said its systems and production changes should support better working capital and margin expansion.
Year-over-year sales were still down sharply, and management said the results are improving but still not where they want them to be. Cash was only $2.4 million versus $9.2 million of debt, so financing remains a live issue, and the company is still dependent on winning back volume from major customers and executing new shelf-space commitments over the coming quarters.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 39.4%
- Shares Outstanding
- 11.82M
- Float Shares
- 4.66M
of shares held by institutions
34 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Minot Wealth Management LLC | 50.00K | 0 |
| Regentatlantic Capital LLC | 21.50K | 0 |
Held by 5 ETFs
Biggest fund positions in REED by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 27, 26 | Warshall Damian Francis | other | 0 |
| Jan 5, 26 | COHANE NEAL | other | 0 |
| Nov 3, 25 | Johnson Keith William | other | 0 |
| Sep 15, 25 | Tu Michael Carl | other | 0 |
| Sep 15, 25 | Reejsinghani Tina Suman | other | 0 |
| Apr 16, 25 | Wallace Cyril Arthur | other | 0 |
| Jun 4, 25 | Era Regenerative Medicine Ltd | buy | 1,075,269 |
| Apr 14, 25 | Bakker Rudolf Johannes Maria | other | 0 |
| Dec 31, 24 | Era Regenerative Medicine Ltd | other | 0 |
| May 23, 23 | Era Regenerative Medicine Ltd | other | 232,108 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our REED coverage
Recent articles, reports, and earnings notes.
No research on REED yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate REED report →Reed's Receives NYSE Deficiency Notification Regarding Stockholders' Equity
globenewswire.com · Aug 14
Head-To-Head Review: Reeds (OTCMKTS:REED) & Pernod Ricard (OTCMKTS:PDRDF)
defenseworld.net · Aug 14
Reed's, Inc. (REED) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 12
Reed's Reports Second Quarter 2026 Results
globenewswire.com · Aug 11
Reed's Schedules Second Quarter 2026 Conference Call for August 12 at 8:30 a.m. ET
globenewswire.com · Jul 29
Reed's Receives NYSE Deficiency Notification Regarding Stockholders' Equity
globenewswire.com · Jun 3
Reed's, Inc. (REED) Q1 2026 Earnings Call Transcript
seekingalpha.com · May 13
Reed's Reports First Quarter 2026 Results
globenewswire.com · May 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.